Home
PODD
PODD News

Latest Insulet Corporation (PODD) News on May 9, 2025

MT Newswires

7 hours ago

RBC Raises Price Target on Insulet to $330 From $325, Keeps Outperform Rating

Thomson Reuters StreetEvents

8 hours ago

Q1 2025 Insulet Corp Earnings Call

Dow Jones Futures Rise As Trump Says 80% China Tariff 'Seems Right'; Robinhood Leads 6 New Buys

Investor's Business Daily

8 hours ago

Dow Jones Futures Rise As Trump Says 80% China Tariff 'Seems Right'; Robinhood Leads 6 New Buys

MT Newswires

9 hours ago

Canaccord Genuity Lifts Price Target on Insulet to $331 From $324, Maintains Buy Rating

MT Newswires

9 hours ago

Oppenheimer Adjusts Price Target on Insulet to $324 From $312, Maintains Outperform Rating

MT Newswires

9 hours ago

Baird Adjusts Price Target on Insulet to $350 From $325, Maintains Outperform Rating

MT Newswires

9 hours ago

Wells Fargo Adjusts Price Target on Insulet to $330 From $322, Maintains Overweight Rating

MT Newswires

9 hours ago

Bernstein Adjusts Price Target on Insulet to $355 From $335, Maintains Outperform Rating

What To Expect From Insulet’s (PODD) Q1 Earnings

StockStory

3 days ago

What To Expect From Insulet’s (PODD) Q1 Earnings

Argus Research

3 days ago

PODD: Raising target price to $285.00

Curious about Insulet (PODD) Q1 Performance? Explore Wall Street Estimates for Key Metrics

Zacks

4 days ago

Curious about Insulet (PODD) Q1 Performance? Explore Wall Street Estimates for Key Metrics

1 Growth Stock with Impressive Fundamentals and 2 to Think Twice About

StockStory

5 days ago

1 Growth Stock with Impressive Fundamentals and 2 to Think Twice About

MT Newswires

10 days ago

Insulet Shares Fall After Wolfe Research Downgrade

MT Newswires

10 days ago

Wolfe Research Downgrades Insulet to Peer Perform From Outperform

Insulet Names New CEO, Expects to Top Revenue Projections

Investopedia

11 days ago

Insulet Names New CEO, Expects to Top Revenue Projections

Ashley McEvoy named Insulet CEO

MedTech Dive

11 days ago

Ashley McEvoy named Insulet CEO

1 Healthcare Stock Worth Your Attention and 2 to Turn Down

StockStory

11 days ago

1 Healthcare Stock Worth Your Attention and 2 to Turn Down

MT Newswires

11 days ago

Insulate Names Ashley McEvoy Chief Executive

Insulet Appoints Ashley McEvoy President and CEO

Business Wire

11 days ago

Insulet Appoints Ashley McEvoy President and CEO

Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger

Simply Wall St.

15 days ago

Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger

Argus Research

17 days ago

PODD: Raising target price to $297.00

4 Medical Product Stocks to Buy From a Challenging Industry

Zacks

22 days ago

4 Medical Product Stocks to Buy From a Challenging Industry

Argus Research

24 days ago

PODD: Raising target price to $282.00

MT Newswires

24 days ago

RBC Cuts Price Target on Insulet to $325 From $340, Keeps Outperform Rating

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

StockStory

a month ago

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength?

Zacks

a month ago

Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength?

5 High-Flying Large-Cap Stocks to Buy Amid Tariff-Led Market Rout

Zacks

a month ago

5 High-Flying Large-Cap Stocks to Buy Amid Tariff-Led Market Rout

Argus Research

a month ago

PODD: Lowering target price to $272.00

PODD Stock Benefits From the Launch of Omnipod 5 in Canada

Zacks

a month ago

PODD Stock Benefits From the Launch of Omnipod 5 in Canada

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

StockStory

a month ago

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

This Insulin Pump Maker Expands Into New Territory And Its Stock Shows Relative Strength

Investor's Business Daily

a month ago

This Insulin Pump Maker Expands Into New Territory And Its Stock Shows Relative Strength

Insulet (NasdaqGS:PODD) Launches Omnipod 5 In Canada As Shares Dip 7%

Simply Wall St.

a month ago

Insulet (NasdaqGS:PODD) Launches Omnipod 5 In Canada As Shares Dip 7%

MT Newswires

a month ago

Citigroup Adjusts Insulet Price Target to $315 From $355, Maintains Buy Rating

Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above

CNW Group

a month ago

Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above

Morningstar Research

a month ago

Analyst Report: Insulet Corporation

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

Business Wire

a month ago

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

StockStory

a month ago

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

Argus Research

a month ago

PODD: Lowering target price to $290.00

3 Reasons Investors Love Insulet (PODD)

StockStory

a month ago

3 Reasons Investors Love Insulet (PODD)

MT Newswires

a month ago

Insulet Insider Sold Shares Worth $501,875, According to a Recent SEC Filing

Argus Research

a month ago

PODD: Rating increased to a BUY

Insulet Gains 62.9% in a Year: What's Driving the Stock?

Zacks

2 months ago

Insulet Gains 62.9% in a Year: What's Driving the Stock?

Insulet (NasdaqGS:PODD) Completes US$450 Million Debt Financing; 7 Day Share Price Up 5%

Simply Wall St.

2 months ago

Insulet (NasdaqGS:PODD) Completes US$450 Million Debt Financing; 7 Day Share Price Up 5%

PODD Stock Gains Following the Launch of Omnipod 5 in Australia

Zacks

2 months ago

PODD Stock Gains Following the Launch of Omnipod 5 in Australia

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

StockStory

2 months ago

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5

Zacks

2 months ago

PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5

LendingTree and AMC Networks have been highlighted as Zacks Bull and Bear of the Day

Zacks

2 months ago

LendingTree and AMC Networks have been highlighted as Zacks Bull and Bear of the Day

Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data

MedTech Dive

2 months ago

Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data

MT Newswires

2 months ago

Insulet Reports Glycemic Improvements With Omnipod Automated Insulin Delivery System

Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections

Business Wire

2 months ago

Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections

3 Tariff-Proof Medical Device Stocks to Watch Amid Trump's MAGA Slogan

Zacks

2 months ago

3 Tariff-Proof Medical Device Stocks to Watch Amid Trump's MAGA Slogan

MT Newswires

2 months ago

Insulet Prices $450 Million Senior Notes Due 2033

Insulet Announces Pricing of Senior Notes Due 2033

Business Wire

2 months ago

Insulet Announces Pricing of Senior Notes Due 2033

Insulet Corporation (PODD): Among the Best Diabetes Stocks to Buy According to Billionaires

Insider Monkey

2 months ago

Insulet Corporation (PODD): Among the Best Diabetes Stocks to Buy According to Billionaires

Insulet Chief Technology Officer Mark Field leaves

MedTech Dive

2 months ago

Insulet Chief Technology Officer Mark Field leaves

MT Newswires

2 months ago

Insulet Plans $450 Million Senior Notes Offering

MT Newswires

2 months ago

Insulet Launches Omnipod 5 Insulin Delivery System in Australia

Insulet Expands Omnipod® 5 to Four More International Markets

Business Wire

2 months ago

Insulet Expands Omnipod® 5 to Four More International Markets

From Injections to Innovation – Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod® 5 in Adults and Children with Type 1 Diabetes

Business Wire

2 months ago

From Injections to Innovation – Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod® 5 in Adults and Children with Type 1 Diabetes

Insulet (NasdaqGS:PODD) Declines 12% After Earnings Reveal Net Income Decrease

Simply Wall St.

2 months ago

Insulet (NasdaqGS:PODD) Declines 12% After Earnings Reveal Net Income Decrease

Insulet to Host Investor Day on June 5, 2025

Business Wire

2 months ago

Insulet to Host Investor Day on June 5, 2025

Insulet (NASDAQ:PODD) shareholders YoY returns are lagging the company's 15% five-year earnings growth

Simply Wall St.

2 months ago

Insulet (NASDAQ:PODD) shareholders YoY returns are lagging the company's 15% five-year earnings growth

Robinhood initiated, MongoDB downgraded: Wall Street’s top analyst calls

TipRanks

2 months ago

Robinhood initiated, MongoDB downgraded: Wall Street’s top analyst calls

MT Newswires

2 months ago

RBC Initiates Insulet at Outperform With $340 Price Target

Argus Research

2 months ago

PODD: Raising target price to $283.00

Morningstar Research

2 months ago

Analyst Report: Insulet Corporation

Tandem’s insulin pump tech wins FDA nod for Type 2 diabetes

MedTech Dive

2 months ago

Tandem’s insulin pump tech wins FDA nod for Type 2 diabetes

Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)

StockStory

2 months ago

Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)

Insulet Sales Keep Rising

FX Empire

2 months ago

Insulet Sales Keep Rising

Argus Research

2 months ago

PODD: Lowering target price to $280.00

Medtronic Stock Gets IBD Rating Lift

Investor's Business Daily

2 months ago

Medtronic Stock Gets IBD Rating Lift

MT Newswires

3 months ago

Redburn Atlantic Adjusts Price Target on Insulet to $315 From $300, Keeps Buy Rating

MT Newswires

3 months ago

Bernstein Adjusts Price Target on Insulet to $335 From $315, Keeps Outperform Rating

Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst

Benzinga

3 months ago

Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst

Morningstar Research

3 months ago

Analyst Report: Insulet Corporation

MT Newswires

3 months ago

Wells Fargo Adjusts Insulet Price Target to $322 From $305

MT Newswires

3 months ago

Citigroup Adjusts Insulet Price Target to $355 From $310

MT Newswires

3 months ago

Stifel Nicolaus Adjusts Insulet Price Target to $293 From $245

MT Newswires

3 months ago

BTIG Research Adjusts Insulet Price Target to $310 From $300

MT Newswires

3 months ago

Leerink Partners Adjusts Insulet Price Target to $314 From $278

MT Newswires

3 months ago

Piper Sandler Adjusts Insulet Price Target to $310 From $285

MT Newswires

3 months ago

Canaccord Genuity Adjusts Insulet Price Target to $324 From $304

MT Newswires

3 months ago

Wolfe Research Adjusts Insulet Price Target to $315 From $265

Insulet Earnings: What To Look For From PODD

StockStory

3 months ago

Insulet Earnings: What To Look For From PODD

Argus Research

3 months ago

PODD: Lowering target price to $295.00

Stay Ahead of the Game With Insulet (PODD) Q4 Earnings: Wall Street's Insights on Key Metrics

Zacks

3 months ago

Stay Ahead of the Game With Insulet (PODD) Q4 Earnings: Wall Street's Insights on Key Metrics

If EPS Growth Is Important To You, Insulet (NASDAQ:PODD) Presents An Opportunity

Simply Wall St.

3 months ago

If EPS Growth Is Important To You, Insulet (NASDAQ:PODD) Presents An Opportunity

Argus Research

3 months ago

PODD: Raising target price to $292.00

Zacks.com featured highlights NVIDIA, AppLovin and Insulet

Zacks

3 months ago

Zacks.com featured highlights NVIDIA, AppLovin and Insulet

NVIDIA & 2 Other Profitable Stocks to Buy in February

Zacks

3 months ago

NVIDIA & 2 Other Profitable Stocks to Buy in February

Here's Why You Should Add PODD Stock to Your Portfolio Now

Zacks

3 months ago

Here's Why You Should Add PODD Stock to Your Portfolio Now

Argus Research

3 months ago

PODD: What does Argus have to say about PODD?

Argus Research

4 months ago

PODD: Raising target price to $290.00

GEHC or PODD: Which Is the Better Value Stock Right Now?

Zacks

4 months ago

GEHC or PODD: Which Is the Better Value Stock Right Now?

Argus Research

4 months ago

PODD: Raising target price to $280.00

PODD Stock Gains From the Launch of Omnipod 5 in Five Countries in EU

Zacks

4 months ago

PODD Stock Gains From the Launch of Omnipod 5 in Five Countries in EU

MT Newswires

4 months ago

Insulet Begins Commercial Sales of Omnipod 5 Insulin Delivery System in 5 More Countries

Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe

Business Wire

4 months ago

Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe

Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Business Wire

4 months ago

Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

MT Newswires

4 months ago

Bernstein Adjusts Price Target on Insulet to $315 From $305, Keeps Outperform Rating

Share on Social Networks: